These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6344858)

  • 1. Subcellular metabolic activation systems: their utility and limitations in predicting organ and species specific carcinogenesis of chemicals.
    Bartsch H; Malaveille C; Camus AM
    Basic Life Sci; 1983; 24():353-75. PubMed ID: 6344858
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of aromatic hydrocarbons on the metabolism of 2-aminoanthracene to mutagenic products in the Ames assay.
    Kawalek JC; Andrews AW
    Carcinogenesis; 1981; 2(12):1367-9. PubMed ID: 7034989
    [No Abstract]   [Full Text] [Related]  

  • 3. Validation and comparative studies on 180 chemicals with S. typhimurium strains and V79 Chinese hamster cells in the presence of various metabolizing systems.
    Bartsch H; Malaveille C; Camus AM; Martel-Planche G; Brun G; Hautefeuille A; Sabadie N; Barbin A; Kuroki T; Drevon C; Piccoli C; Montesano R
    Mutat Res; 1980 Jul; 76(1):1-50. PubMed ID: 6993936
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic differences in metabolism of polycyclic aromatic carcinogens and aromatic amines by mouse liver microsomes. Detection by DNA binding of metabolites and by mutagenicity in histidine-dependent Salmonella typhimurium in vitro.
    Levitt RC; Pelkonen O; Okey AB; Nebert DW
    J Natl Cancer Inst; 1979 Apr; 62(4):947-55. PubMed ID: 372661
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic activation and deactivation of mutagens and carcinogens.
    De Flora S
    Ital J Biochem; 1979; 28(2):81-103. PubMed ID: 399955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity testing with Salmonella microsome test.
    Greim H; Göggelmann W; Summer KH; Wolff T
    Arch Toxicol; 1980 Nov; 46(1-2):31-40. PubMed ID: 7016073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of procarcinogens by subcellular enzyme fractions in the C3H 10T1/2 and BALB/c 3T3 cell transformation systems.
    Schechtman LM
    IARC Sci Publ; 1985; 67():137-62. PubMed ID: 3913640
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenesis in Salmonella after metabolic activation of carcinogenic azo dyes and their isomers by liver S9 from rats, mice and hamsters.
    Mori Y; Niwa T; Toyoshi K; Hirano K; Sugiura M
    Mutat Res; 1983 Aug; 121(2):95-102. PubMed ID: 6348534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of nitrosamines to mutagens by rat and rabbit nasal, lung and liver S-9 homogenates.
    Dahl AR
    Adv Exp Med Biol; 1986; 197():367-72. PubMed ID: 2945408
    [No Abstract]   [Full Text] [Related]  

  • 11. Mutagenicity of carcinogenic mycotoxins in Salmonella typhimurium.
    Ueno Y; Kubota K; Ito T; Nakamura Y
    Cancer Res; 1978 Mar; 38(3):536-42. PubMed ID: 342092
    [No Abstract]   [Full Text] [Related]  

  • 12. Non-mutagenicity of 3-dimethylamino-psi-saccharin to Salmonella typhimurium.
    Ashby J; Callander RD
    Cancer Lett; 1983 Jul; 19(3):343-5. PubMed ID: 6349789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical analysis of Salmonella test data and comparison to results of animal cancer tests.
    McCann J; Gold LS; Horn L; McGill R; Graedel TE; Kaldor J
    Mutat Res; 1988; 205(1-4):183-95. PubMed ID: 3285186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay for mutagenicity of bile in Sprague-Dawley rats treated subcutaneously with intestinal carcinogens.
    Moriya M; Ohta T; Sugiyama F; Miyazawa T; Shirasu Y
    J Natl Cancer Inst; 1979 Oct; 63(4):977-82. PubMed ID: 384011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97.
    Sakai M; Yoshida D; Mizusaki S
    Mutat Res; 1985; 156(1-2):61-7. PubMed ID: 3889628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of metabolic activation systems used in short-term tests for carcinogens.
    Bigger CA; Dipple A
    Dev Toxicol Environ Sci; 1980; 8():171-4. PubMed ID: 6796372
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of carcinogens in the Salmonella mutagenicity assay by hamster and rat liver S-9 preparations.
    Raineri R; Poiley JA; Pienta RJ; Andrews AW
    Environ Mutagen; 1981; 3(1):71-84. PubMed ID: 7021144
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutagenicity of 4-chloromethylbiphenyl in the Salmonella/microsome assay.
    Pagano DA; Shelby MD
    Mutat Res; 1982; 100(1-4):67-70. PubMed ID: 7035904
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagenicity of the antiparasitic drug Vermox for Salmonella typhimurium His- tester strains.
    Paulíková H; Dobiás L
    Mutat Res; 1981 Dec; 90(4):463-8. PubMed ID: 7038464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.